These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6874004)

  • 1. Monoclonal antibodies to rat sarcomata. II. A syngeneic IgG2b antibody with anti-tumour activity.
    North SM; Dean CJ
    Immunology; 1983 Aug; 49(4):667-71. PubMed ID: 6874004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies to rat sarcomata. I. Immunization procedures and source of lymphoid cells for hybridoma production.
    North SM; Styles JM; Hobbs SM; Dean CJ
    Immunology; 1982 Nov; 47(3):397-405. PubMed ID: 7129525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination with syngeneic monoclonal anti-idiotype protects against a tumour challenge.
    Dunn PL; Johnson CA; Styles JM; Pease SS; Dean CJ
    Immunology; 1987 Feb; 60(2):181-6. PubMed ID: 3817870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic studies of radiolabelled rat monoclonal antibodies recognising syngeneic sarcoma antigens. II. Effect of host age and immune status.
    Eccles SA; Purvies HP; Styles JM; Hobbs SM; Dean CJ
    Cancer Immunol Immunother; 1989; 30(1):13-20. PubMed ID: 2598171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes.
    Milas L; Hunter N; Mason K; Withers HR
    Cancer Res; 1974 Jan; 34(1):61-71. PubMed ID: 4809463
    [No Abstract]   [Full Text] [Related]  

  • 6. Syngeneic antitumour antibodies in rats: clearance of cell-bound antibody in vivo and in vitro.
    Dean CJ; Hobbs SM; Hopkins JU; North SM; Styles JM
    Br J Cancer; 1982 Aug; 46(2):190-7. PubMed ID: 7150472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological competence of spleen cells from rats bearing syngeneic or autochthonous tumours.
    Medzihradský J; Koníková E; Novotná L
    Neoplasma; 1972; 19(2):105-10. PubMed ID: 4401919
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetic studies of radiolabelled rat monoclonal antibodies recognising syngeneic sarcoma antigens. I. Comparison of IgG subclasses.
    Eccles SA; Purvies HP; Styles JM; Hobbs SM; Dean CJ
    Cancer Immunol Immunother; 1989; 30(1):5-12. PubMed ID: 2598175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The kinetics of mononuclear phagocyte infiltration in neoplasms: reactions to non-specific stimuli in a rat fibrosarcoma.
    Woods AE; Papadimitriou JM; van Bruggen I
    J Pathol; 1983 May; 140(1):41-50. PubMed ID: 6304272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of monoclonal antibodies utilizing the host anti-idiotypic network.
    Hatzistilianou MN; Sivolapenko GB; Courtenay-Luck NS; Epenetos AA; Ritter MA
    In Vivo; 1995; 9(2):139-44. PubMed ID: 7548789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociation between tumour resistance and delayed-type hypersensitivity to tumour-associated antigens in the mouse.
    Henderson DC; Parker D; Turk JL
    Immunology; 1980 Jan; 39(1):1-9. PubMed ID: 7380461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity of syngeneic monoclonal antibodies against cell surface antigens of chemically induced mouse fibrosarcomas.
    Klein PA
    Transplant Proc; 1981 Dec; 13(4):1762-4. PubMed ID: 7330965
    [No Abstract]   [Full Text] [Related]  

  • 13. Radioimmunotherapy of micrometastases in lung with vascular targeted 213Bi.
    Kennel SJ; Boll R; Stabin M; Schuller HM; Mirzadeh S
    Br J Cancer; 1999 Apr; 80(1-2):175-84. PubMed ID: 10389994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production and characterization of monoclonal antibodies to bovine immunoglobulin G2.
    Srikumaran S; Guidry AJ; Goldsby RA
    Am J Vet Res; 1982 Jan; 43(1):21-5. PubMed ID: 7091814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of two anti-tumour monoclonal antibody preparations.
    Price MR; Dennick RG; Fang CY; Hannant D; Embleton MJ; Gunn B; Baldwin RW
    Arch Geschwulstforsch; 1981; 51(4):302-9. PubMed ID: 6947720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibody homodimers: enhanced antitumor activity in nude mice.
    Wolff EA; Schreiber GJ; Cosand WL; Raff HV
    Cancer Res; 1993 Jun; 53(11):2560-5. PubMed ID: 8495420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epitope-specific antibody response to HT-1080 fibrosarcoma cells by mimotope immunization.
    Popkov M; Sidrac-Ghali S; Alakhov V; Mandeville R
    Clin Cancer Res; 2000 Sep; 6(9):3629-35. PubMed ID: 10999755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-mediated immune responses to syngeneic ultraviolet-induced tumours. V. Assessment of accessory and antigen-presenting cell capabilities of normal and ultraviolet-irradiated mice in the generation of anti-tumour cytotoxic effector cells in vitro.
    Lynch DH; Gurish MF; Daynes RA
    Immunology; 1982 Sep; 47(1):49-59. PubMed ID: 6981587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine splenic changes in response to syngeneic and allogeneic neoplasias.
    Braylan RC; Rumi L; Dosne Pasqualini C
    Medicina (B Aires); 1972; 32(5):505-10. PubMed ID: 4649563
    [No Abstract]   [Full Text] [Related]  

  • 20. Rat monoclonal antibodies which inhibit the in vitro multiplication of Plasmodium knowlesi.
    Deans JA; Alderson T; Thomas AW; Mitchell GH; Lennox ES; Cohen S
    Clin Exp Immunol; 1982 Aug; 49(2):297-309. PubMed ID: 6751636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.